Reason: Labeling: Label mix-up - ephedrine syringes mislabeled as phenylephrine.
Distributed: CO, GA, PA, SD, WAReason: Subpotent product in addition to having out-of-specification results for impurities.
Distributed: USA NationwideReason: Presence of Foreign Substance: This oil based product may contain trace amounts of water for injection (WFI).
Distributed: Nationwide within the United StatesReason: CGMP Deviations: Presence of N-nitroso-duloxetine impurity above FDA recommended interim limit
Distributed: Product distributed to CA, FL, OK, KS and CTReason: Failed Impurities/Degradation Specifications
Distributed: US Nationwide.Reason: Lack of Assurance of Sterility.
Distributed: UT onlyReason: Failed Release Testing: Out of specification for particulate matter test.
Distributed: TX, PAReason: Microbial Contamination of Non-Sterile Products - Presence of Acetobacter nitrogenifigens bacteria
Distributed: USA NationwideReason: Microbial Contamination of Non-Sterile Products - Presence of Acetobacter nitrogenifigens bacteria
Distributed: USA NationwideReason: Presence of Particulate Matter: Potential for black particulates in the drug product.
Distributed: Nationwide in the USA